Peptides and pseudopeptides as SIRT6 deacetylation inhibitors

ACS Medicinal Chemistry Letters

Volumn 3, Issue 12, 2012, Pages 969-974

  Kokkonen, Piia ^a   Rahnasto Rilla, Minna ^a   Kiviranta, Päivi H ^a   Huhtiniemi, Tero ^a   Laitinen, Tuomo ^a   Poso, Antti ^a   Jarho, Elina ^a   Lahtela Kakkonen, Maija ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

inhibitor; peptide; pseudopeptide; SIRT6; sirtuin; substrate based inhibitor

Indexed keywords

HISTONE DEACETYLASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDE DERIVATIVE; PSEUDOPEPTIDE; SIRTUIN 1; SIRTUIN 2; SIRTUIN 6; SIRTUIN 6 DEACETYLATION INHIBITOR; UNCLASSIFIED DRUG;

AGING; ARTICLE; CARBOHYDRATE METABOLISM; CELL PROTECTION; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG POTENCY; HYDROGEN BOND; IC 50; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN FAMILY; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION;

EID: 84871213843     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300139n     Document Type: Article

References (28)

1. Baur, J. A.; Ungvari, Z.; Minor, R. K.; Le Couteur, D. G.; de Cabo, R. Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Discovery 2012, 11, 443-461
2. Chen, L. Medicinal chemistry of sirtuin inhibitors Curr. Med. Chem. 2011, 18, 1936-1946
3. Pan, P. W.; Feldman, J. L.; Devries, M. K.; Dong, A.; Edwards, A. M.; Denu, J. M. Structure and biochemical functions of SIRT6 J. Biol. Chem. 2011, 286, 14575-14587
4. Du, J.; Jiang, H.; Lin, H. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD Biochemistry 2009, 48, 2878-2890
5. Yasuda, M.; Wilson, D. R.; Fugmann, S. D.; Moaddel, R. Synthesis and characterization of SIRT6 protein coated magnetic beads: Identification of a novel inhibitor of SIRT6 deacetylase from medicinal plant extracts Anal. Chem. 2011, 83, 7400-7407
6. Mao, Z.; Hine, C.; Tian, X.; Van Meter, M.; Au, M.; Vaidya, A.; Seluanov, A.; Gorbunovaa, V. SIRT6 promotes DNA repair under stress by activating PARP1 Science 2011, 332, 1443-1446
7. Mostoslavsky, R.; Chua, K. F.; Lombard, D. B.; Pang, W. W.; Fischer, M. R.; Gellon, L.; Liu, P.; Mostoslavsky, G.; Franco, S.; Murphy, M. M.; Mills, K. D.; Patel, P.; Hsu, J. T.; Hong, A. L.; Ford, E.; Cheng, H. L.; Kennedy, C.; Nunez, N.; Bronson, R.; Frendewey, D.; Auerbach, W.; Valenzuela, D.; Karow, M.; Hottiger, M. O.; Hursting, S.; Barrett, J. C.; Guarente, L.; Mulligan, R.; Demple, B.; Yancopoulos, G. D.; Alt, F. W. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 Cell 2006, 124, 315-329
8. Kanfi, Y.; Naiman, S.; Amir, G.; Peshti, V.; Zinman, G.; Nahum, L.; Bar-Joseph, Z.; Cohen, H. Y. The sirtuin SIRT6 regulates lifespan in male mice Nature 2012, 483, 218-221
9. Van Meter, M.; Mao, Z.; Gorbunova, V.; Seluanov, A. Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair Aging (Albany NY) 2011, 3, 829-835
10. Kaidi, A.; Weinert, B. T.; Choudhary, C.; Jackson, S. P. Human SIRT6 promotes DNA end resection through CtIP deacetylation Science 2010, 329, 1348-1353
11. Kanfi, Y.; Peshti, V.; Gil, R.; Naiman, S.; Nahum, L.; Levin, E.; Kronfeld-Schor, N.; Cohen, H. Y. SIRT6 protects against pathological damage caused by diet-induced obesity Aging Cell 2010, 9, 162-173
12. Yu, S. S.; Cai, Y.; Ye, J. T.; Pi, R. B.; Chen, S. R.; Liu, P. Q.; Shen, X. Y.; Ji, Y. Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-kappaB-dependent transcriptional activity Br. J. Pharmacol. 2012, 10.1111/j.1476-5381.2012.01903.x
13. Michishita, E.; McCord, R. A.; Berber, E.; Kioi, M.; Padilla-Nash, H.; Damian, M.; Cheung, P.; Kusumoto, R.; Kawahara, T. L.; Barrett, J. C.; Chang, H. Y.; Bohr, V. A.; Ried, T.; Gozani, O.; Chua, K. F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin Nature 2008, 452, 492-496
14. Michishita, E.; McCord, R. A.; Boxer, L. D.; Barber, M. F.; Hong, T.; Gozani, O.; Chua, K. F. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6 Cell Cycle 2009, 8, 2664-2666
15. Yang, B.; Zwaans, B. M.; Eckersdorff, M.; Lombard, D. B. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability Cell Cycle 2009, 8, 2662-2663
16. Xiao, C.; Kim, H. S.; Lahusen, T.; Wang, R. H.; Xu, X.; Gavrilova, O.; Jou, W.; Gius, D.; Deng, C. X. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice J. Biol. Chem. 2010, 285, 36776-36784
17. Bruzzone, S.; Fruscione, F.; Morando, S.; Ferrando, T.; Poggi, A.; Garuti, A.; D'Urso, A.; Selmo, M.; Benvenuto, F.; Cea, M.; Zoppoli, G.; Moran, E.; Soncini, D.; Ballestrero, A.; Sordat, B.; Patrone, F.; Mostoslavsky, R.; Uccelli, A.; Nencioni, A. Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE PLoS One 2009, 4, e7897
18. Schlicker, C.; Boanca, G.; Lakshminarasimhan, M.; Steegborn, C. Structure-based development of novel sirtuin inhibitors Aging (Albany NY) 2011, 3, 852-872
19. Huhtiniemi, T.; Salo, H. S.; Suuronen, T.; Poso, A.; Salminen, A.; Leppanen, J.; Jarho, E.; Lahtela-Kakkonen, M. Structure-based design of pseudopeptidic inhibitors for SIRT1 and SIRT2 J. Med. Chem. 2011, 54, 6456-6468
20. Huhtiniemi, T.; Suuronen, T.; Lahtela-Kakkonen, M.; Bruijn, T.; Jaaskelainen, S.; Poso, A.; Salminen, A.; Leppanen, J.; Jarho, E. N(epsilon)-Modified lysine containing inhibitors for SIRT1 and SIRT2 Bioorg. Med. Chem. 2010, 18, 5616-5625
21. Kiviranta, P. H.; Suuronen, T.; Wallen, E. A.; Leppanen, J.; Tervonen, J.; Kyrylenko, S.; Salminen, A.; Poso, A.; Jarho, E. M. N(epsilon)-thioacetyl- lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors J. Med. Chem. 2009, 52, 2153-2156
22. Jin, L.; Wei, W.; Jiang, Y.; Peng, H.; Cai, J.; Mao, C.; Dai, H.; Choy, W.; Bemis, J. E.; Jirousek, M. R.; Milne, J. C.; Westphal, C. H.; Perni, R. B. Crystal structures of human SIRT3 displaying substrate-induced conformational changes J. Biol. Chem. 2009, 284, 24394-24405
23. Smith, B. C.; Denu, J. M. Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide Biochemistry 2007, 46, 14478-14486
24. Fatkins, D. G.; Zheng, W. Substituting N(epsilon)-thioacetyl-lysine for N(epsilon)-Acetyl-lysine in peptide substrates as a general approach to inhibiting human NAD(+)-dependent protein deacetylases Int. J. Mol. Sci. 2008, 9, 1-11
25. Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics J. Mol. Graph. 1996, 14, 33-38
26. Cosgrove, M. S.; Bever, K.; Avalos, J. L.; Muhammad, S.; Zhang, X.; Wolberger, C. The structural basis of sirtuin substrate affinity Biochemistry 2006, 45, 7511-7521
27. SYBYL-X 1.2; Tripos International: St. Louis, MO, 2011.
28. Glide version 5.7; Schrödinger, LLC: New York, NY, 2011.